Promising ROd-cone DYstrophy Gene therapY

计划入组 33 人 · 首次发布于 2023 年 3 月 1 日

Rod and Cone Mediated Function in Retinal Disease

计划入组 500 人 · 首次发布于 2015 年 12 月 1 日

Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease

计划入组 165 人 · 首次发布于 2020 年 2 月 28 日

FOV 2501

Brain-derived neurotrophic factor

plasma-derived factor XI

MAGNESIUM FACTOR PTY LTD

Australia

MOTHER SUN PROTECTION FACTOR PTY LTD

Australia

DENMAR INTERNATIONAL PTY. LTD.

Australia

SparingVision Completes Dosing in Phase I/II Trial for Gene-Agnostic Retinitis Pigmentosa Therapy SPVN06

FDA Grants Fast Track Status to BlueRock's Novel Cell Therapy for Inherited Retinal Diseases

FDA Grants Orphan Drug Designation to Skyline Therapeutics' SKG1108 for Retinitis Pigmentosa